Role of K+ channels in arteriolar vasodilation mediated by integrin interaction with RGD-containing peptide

Am J Physiol. 1998 Oct;275(4):H1449-54. doi: 10.1152/ajpheart.1998.275.4.H1449.

Abstract

Integrins are transmembrane adhesion receptors found on most cells, including vascular smooth muscle cells. Several integrins bind to the conserved amino acid sequence Arg-Gly-Asp (RGD), and synthetic RGD-containing peptides can cause endothelium-independent arteriolar vasodilation by interacting with the alphavbeta3-integrin expressed by vascular smooth muscle. We hypothesized that RGD peptide-induced vasodilation involves K+ channels. Rat cremaster arterioles were treated with cRGD (GPenGRGDSPCA) in the presence or absence of the nonselective K+ channel inhibitor tetraethylammonium (TEA, 20 mM). TEA caused arterioles to constrict by 19 +/- 5% and inhibited cRGD-induced vasodilation (n = 7, P < 0.05). Vessels preconstricted with phenylephrine (5 x 10(-7) M) showed no significant inhibition of the dilatory response to cRGD, indicating that inhibition by TEA was not related to increased vasomotor tone. Further evidence for the involvement of K+ channels was obtained by addition of 100 mM KCl (n = 5), which inhibited vasodilation caused by cRGD. Inhibition of large and small conductance, Ca2+-activated K+ channels with iberiotoxin (100 nM) or apamin (25 nM), respectively, had no effect on cRGD-induced vasodilation. Partial inhibition of vasodilation was observed with inhibitors of voltage-gated (4-aminopyridine, 1 mM), ATP-sensitive (glibenclamide, 1 microM), and inward rectifying (barium, 50 microM) K+ channels. These data support the hypothesis that integrin-signaling pathways leading to arteriolar vasodilation may involve modulation of K+ channel function.

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Animals
  • Arterioles / drug effects
  • Arterioles / physiology*
  • In Vitro Techniques
  • Integrins / drug effects
  • Integrins / physiology*
  • Male
  • Muscle, Smooth, Vascular / drug effects
  • Muscle, Smooth, Vascular / physiology
  • Oligopeptides / pharmacology*
  • Potassium Channel Blockers
  • Potassium Channels / drug effects
  • Potassium Channels / physiology*
  • Potassium Chloride / pharmacology
  • Rats
  • Rats, Sprague-Dawley
  • Tetraethylammonium / pharmacology
  • Vasodilation / drug effects
  • Vasodilation / physiology*

Substances

  • GpenGRGDSPCA
  • Integrins
  • Oligopeptides
  • Potassium Channel Blockers
  • Potassium Channels
  • Tetraethylammonium
  • Potassium Chloride